{
    "Trade/Device Name(s)": [
        "URYXXON 200"
    ],
    "Submitter Information": "MACHEREY-NAGEL GmbH & Co. KG",
    "510(k) Number": "K051034",
    "Predicate Device Reference 510(k) Number(s)": [
        "K960546"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JIL",
        "JIP",
        "CDM",
        "CEN",
        "JIN",
        "JIR",
        "JJB",
        "JMA",
        "JMT",
        "KSL",
        "LJX",
        "KQO"
    ],
    "Summary Letter Date": "November 22, 2005",
    "Summary Letter Received Date": "October 21, 2005",
    "Submission Date": "October 21, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1340"
    ],
    "Regulation Name(s)": [
        "Urinary glucose (non-quantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology",
        "other"
    ],
    "Analyte(s)": [
        "Blood",
        "Urobilinogen",
        "Bilirubin",
        "Protein",
        "Nitrite",
        "Ketones",
        "Ascorbic acid",
        "Glucose",
        "pH",
        "Specific gravity",
        "Leucocytes"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "URYXXON 200 Urine Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Reflectance photometry"
    ],
    "Methodologies": [
        "Semi-quantitative analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for URYXXON 200 Urine Analyzer utilizing reflectance photometry for semi-quantitative measurement of urine analytes using Medi-Test Combi 11 strips.",
    "Indications for Use Summary": "In vitro diagnostic aid using urine specimens for screening for diabetes, metabolic abnormalities, liver diseases, biliary and hepatic obstructions, and diseases of the kidneys and urinary tract.",
    "fda_folder": "Clinical Chemistry"
}